FDA Warning Wire: Web Sales Of Banned Obesity Drug

Law360, New York (January 23, 2018, 7:47 PM EST) -- The U.S. Food and Drug scolded the University of California, Los Angeles, for an online promotion of a unapproved drug being studied for its use in detecting prostate cancer cells and told a network of online pharmacies to stop selling a forbidden weight loss drug to Americans.

Here's this week's roundup of the agency's enforcement actions:

UCLA Promoting Investigational Drug

The FDA slammed UCLA for promoting, as safe and effective, a drug used in a method for detecting prostate cancer cells that hasn't yet been approved...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.